Tamsulosin is indicated for the treatment of functional symptoms (i.e. urinary retention) of benign prostatic hyperplasia (prostate enlargement).

MOA: Relaxes the muscles in the prostate gland and urethra thereby increasing the urinary flow-rate and an improvement in obstructive symptoms.

Supply Criteria

Male patient aged between 45 and 75 years 

Symptoms of BPH present for a minimum of three months

A two-week supply of tamsulosin can be supplied initially

If there has been an improvement in urinary symptoms within the initial two weeks, a further supply of four weeks can be made

After six weeks, a further supply can be made only where the patient confirms that the doctor has carried out a clinical assessment and agreed further supplies are appropriate.

Counselling points

One capsule to be taken after the same meal each day

Modified-release preparations should be swallowed whole: not crushed or chewed

Patients should see their doctor within six weeks of starting treatment

Patients should see their doctor every 12 months for a clinical review

Drowsiness or dizziness may affect performance of skilled tasks

Patients should be advised that if they experience any dizziness or weakness they should sit or lie down until the symptoms have gone